Millipore Sigma Vibrant Logo

MAB2630 Anti-KRIT-1 Antibody, clone 15

View Products on Sigmaaldrich.com
MAB2630
100 µg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited Availability
Limited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Special Offers

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Specifications Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      HICC, IPMPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMAB2630
      DescriptionAnti-KRIT-1 Antibody, clone 15
      Alternate Names
      • Cerebral cavernous malformations 1 protein
      • Krev interaction trapped 1
      Background InformationCerebral cavernous malformation (CCM), a disease associated with defective endothelial junctions, results from autosomal dominant CCM1 mutations that cause a loss of KRIT-1 protein function. CCM1 has been identified as the KRIT-1 gene. The protein product, KRIT-1, also known as Krev interaction trapped protein 1, is a microtubule-associated protein involved in endothelial cell-cell and cell-extracellular matrix interactions. KRIT-1 binds to Rap1 that maintains the integrity of endothelial junctions. It is reported that KRIT-1 colocalizes and is physically associated with junctional proteins via its band 4.1/ezrin/radixin/moesin (FERM) domain, (Glading, 2007).
      References
      Product Information
      FormatPurified
      Control
      • HeLa, A431, and HUVECs.
      PresentationPurified mouse monoclonal IgG2bκ in buffer containing 0.1 M Tris-Glycine (pH 7.4, 150 mM NaCl) with 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationAnti-KRIT-1 Antibody, clone 15 detects level of KRIT-1 & has been published & validated for use in IC, IP & WB.
      Key Applications
      • Immunocytochemistry
      • Immunoprecipitation
      Biological Information
      ImmunogenGST-tagged recombinant protein corresponding to human KRIT-1 at and around the FERM domain.
      EpitopeFERM domain
      Clone15B2
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      HostMouse
      SpecificityThe antibody recognizes KRIT-1.
      IsotypeIgG2bκ
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Entrez Gene SummaryThis gene encodes a protein containing four ankyrin repeats, a band 4.1/ezrin/radixin/moesin (FERM) domain, and multiple NPXY sequences. The encoded protein is localized in the nucleus and cytoplasm. It binds to integrin cytoplasmic domain-associated protein-1 alpha (ICAP1alpha), and plays a critical role in beta1-integrin-mediated cell proliferation. It associates with junction proteins and RAS-related protein 1A (Rap1A), which requires the encoded protein for maintaining the integrity of endothelial junctions. It is also a microtubule-associated protein and may play a role in microtubule targeting. Mutations in this gene result in cerebral cavernous malformations. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq].
      Gene Symbol
      • KRIT1
      • CAM
      • CCM1
      Purification MethodProtein G Purified
      UniProt Number
      UniProt SummarySUBUNIT STRUCTURE: Interacts with RAP1A.

      SUBCELLULAR LOCATION: Membrane; Peripheral membrane protein Probable.

      TISSUE SPECIFICITY: Low levels in brain. Very weak expression found in heart and muscle.

      INVOLVEMENT IN DISEASE: Defects in KRIT1 are the cause of cerebral cavernous malformations type 1 (CCM1) [MIM:116860]. Cerebral cavernous malformations (CCMs) are congenital vascular anomalies of the central nervous system that can result in hemorrhagic stroke, seizures, recurrent headaches, and focal neurologic deficits. CCMs have an incidence of 0.1%-0.5% in the general population and usually present clinically during the 3rd to 5th decade of life. The lesions are characterized by grossly enlarged blood vessels consisting of a single layer of endothelium and without any intervening neural tissue, ranging in diameter from a few millimeters to several centimeters.

      SEQUENCE SIMILARITIES: Contains 4 ANK repeats.

      Contains 1 FERM domain.
      Molecular Weight~ 84 kDa
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceImmunocytochemistry Analysis: 1:500 dilution of this antibody detected KRIT-1 in HeLa, A431, and HUVECs.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalog Number GTIN
      MAB2630 04053252662249

      Documentation

      Anti-KRIT-1 Antibody, clone 15 SDS

      Title

      Safety Data Sheet (SDS) 

      Anti-KRIT-1 Antibody, clone 15 Certificates of Analysis

      TitleLot Number
      Anti-KRIT-1, clone 15B2 - 2028603 2028603
      Anti-KRIT-1, clone 15B2 - 2196100 2196100
      Anti-KRIT-1, clone 15B2 - 3956120 3956120
      Anti-KRIT-1, clone 15B2 - NG1868834 NG1868834
      Anti-KRIT-1, clone 15B2 - NG1941998 NG1941998
      Anti-KRIT-1, clone 15B2 - NRG1693919 NRG1693919
      Anti-KRIT-1, clone 15B2 -2554914 2554914
      Anti-KRIT-1, clone 15B2 -2568132 2568132
      Anti-KRIT-1, clone 15B2 -2683926 2683926
      Anti-KRIT-1, clone 15B2 -2891866 2891866